KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Total Liabilities (2018 - 2025)

Historic Total Liabilities for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to $161.8 million.

  • Aurinia Pharmaceuticals' Total Liabilities rose 24.67% to $161.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.8 million, marking a year-over-year increase of 24.67%. This contributed to the annual value of $173.2 million for FY2024, which is 179.83% up from last year.
  • Aurinia Pharmaceuticals' Total Liabilities amounted to $161.8 million in Q3 2025, which was up 24.67% from $167.3 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Total Liabilities ranged from a high of $173.2 million in Q4 2024 and a low of $46.8 million during Q1 2021
  • For the 5-year period, Aurinia Pharmaceuticals' Total Liabilities averaged around $113.7 million, with its median value being $154.7 million (2025).
  • In the last 5 years, Aurinia Pharmaceuticals' Total Liabilities plummeted by 914.2% in 2021 and then skyrocketed by 16825.63% in 2023.
  • Over the past 5 years, Aurinia Pharmaceuticals' Total Liabilities (Quarter) stood at $64.3 million in 2021, then grew by 1.79% to $65.4 million in 2022, then surged by 160.0% to $170.1 million in 2023, then grew by 1.8% to $173.2 million in 2024, then dropped by 6.59% to $161.8 million in 2025.
  • Its Total Liabilities was $161.8 million in Q3 2025, compared to $167.3 million in Q2 2025 and $154.7 million in Q1 2025.